Last reviewed · How we verify
Control Analgesic regimen
A control analgesic regimen combines multiple pain-relief agents to manage pain through complementary mechanisms.
A control analgesic regimen combines multiple pain-relief agents to manage pain through complementary mechanisms. Used for Acute and chronic pain management.
At a glance
| Generic name | Control Analgesic regimen |
|---|---|
| Also known as | Epidural Bupivacaine |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | FDA-approved |
Mechanism of action
Control analgesic regimens typically employ a multimodal approach, combining agents such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and/or adjuvant analgesics to target pain through different pathways—reducing inflammation, blocking pain signal transmission, and modulating pain perception. This combination approach aims to improve efficacy while potentially reducing the dose-dependent adverse effects of any single agent.
Approved indications
- Acute and chronic pain management
Common side effects
- Nausea
- Constipation
- Dizziness
- Drowsiness
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision (NA)
- SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety (PHASE2)
- EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA (PHASE2)
- Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair (NA)
- A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery (NA)
- Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Control Analgesic regimen CI brief — competitive landscape report
- Control Analgesic regimen updates RSS · CI watch RSS
- Ain Shams University portfolio CI